BioSpace News Archive

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the pricing of an underwritten public offering of 20,000,000 shares of its common stock at a price to the public of $1.90 per share.

New grant expands coverage of key U.S. platform patent to Europe ENDRA Life Sciences Inc.

BOSTON, MA / ACCESSWIRE / July 22, 2020 / AG Mednet , a technology company streamlining, automating and increasing data quality for clinical trials, announces significant expansion to its Submission Quality and Compliance (SQC) Toolkit.

Ultivue, Inc. today announced a collaborative partnership with OracleBio to help further insights and advance personalized tumor characterization in translational and clinical oncology research and drug development using multiplex immunofluorescence staining and imaging.

PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced that it has launched two online, free-access PerkinElmer COVID-19 Data Dashboards to help the global scientific community accelerate the discovery of COVID-19 antivirals and vaccines. These dashboards are powered

According to the report, the global GAS pharyngitis diagnostics market was valued at approximately US$ 163.1 Mn in 2018. It is expected to expand at a CAGR of 2.5% during the forecast period from 2019 to 2027.

Transparency Market Research has published a new report titled, Cleanroom Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the Company has entered into an agreement with Vigene Biosciences (“Vigene”) to manufacture AdCOVIDTM, Altimmune’s single-dose intranasal vaccine candidate for COVID-19.

A growing number of chemicals in pesticides, flame retardants, and certain plastics have been linked to widespread health problems including infertility, diabetes, and impaired brain development, a set of reviews of hundreds of studies concludes.

IntegriChain, a leading data and managed services company helping Life Sciences manufacturers deliver access to innovative therapies that significantly improve patient lives, today announced the summer release of its ICyte Platform of access data and analytics solutions.